|View printer-friendly version|
|June 18, 2004 5:08 p.m.|
|Teva Announces Approval Of Metformin Hcl Er Tablets|
Jerusalem, Israel, June 18, 2004 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the company's ANDA for Metformin HCl Extended-Release Tablets, 500 mg. Shipment of this product will begin immediately.